MMP14 gene polymorphisms in chronic obstructive pulmonary disease

International Journal of Molecular Medicine

Volumn 17, Issue 4, 2006, Pages 621-626

  Saitoh, Wataru ^a   Sakamoto, Tohru ^a   Hegab, Ahmed E ^a   Nomura, Akihiro ^a   Ishii, Yukio ^a   Morishima, Yuko ^a   Kai, Sachiko ^a   Iizuka, Takashi ^a   Kiwamoto, Takumi ^a   Matsuno, Yosuke ^a   Massoud, Hosam H ^b   Massoud, Hosny M ^b   Hassanein, Khalid M ^b   Sekizawa, Kiyohisa ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Chronic obstructive pulmonary disease; Haplotype; Linkage disequilibrium; MMP14; Polymorphism

Indexed keywords

MATRIX METALLOPROTEINASE;

AGED; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; EGYPT; ENZYMOLOGY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; JAPAN; LUNG FUNCTION TEST; MALE; PATHOPHYSIOLOGY; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; EGYPT; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS;

EID: 33746729000     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.4.621     Document Type: Article

References (33)

1. U.S. Department of Health and Human Services: The health consequences of smoking: chronic obstructive lung disease: a report of the surgeon general. Rockville MD: U.S. Department of Health and Human Services, Public Health Service. Office on Smoking and Health; Document No. DHHS (PHS) 84-50205, 1984.
2. Cantin A and Crystal RG: Oxidants, antioxidants and the pathogenesis of emphysema. Eur J Respir Dis 66 (Suppl 139): 7-17, 1985.
3. Hunninghake GW and Crystal RG: Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis 128: 833-838, 1983.
4. Morrison D, Rahman I, Lannan S and MacNee W: Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers. Am J Respir Crit Care Med 159: 473-479, 1999.
5. Sansores RH, Abboud RT, Becerril C, et al: Effect of exposure of guinea pigs to cigarette smoke on elastolytic activity of pulmonary macrophages. Chest 112: 214-219, 1997.
6. Fletcher C and Peto R: The natural history of chronic airflow obstruction. Br Med J 1: 1645-1648, 1977.
7. D'Armiento J, Dalal SS, Okada Y, Berg RA and Chada K: Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 71: 955-961, 1992.
8. Hautamaki RD, Kobayashi DK, Senior RM and Shapiro SD: Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277: 2002-2004, 1997.
9. Zheng T, Zhu Z, Wang Z, et al: Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 106: 1081-1093, 2000.
10. Finlay GA, O'Driscoll LR, Russell KJ, et al: Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 156: 240-247, 1997.
11. Ohnishi K, Takagi M, Kurokawa Y, Satomi S and Konttinen YT: Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest 78: 1077-1087, 1998.
12. Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C and Selman M: Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 117: 684-694, 2000. (Pubitemid 30152206)
13. Imai K, Dalal SS, Chen ES, et al: Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med 163: 786-791, 2001. (Pubitemid 32230844)
14. Jo Y, Yeon J, Kim HJ and Lee ST: Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. Biochem J 345: 511-519, 2000. (Pubitemid 30099080)
15. Hegab AE, Sakamoto T, Uchida Y, et al: CLCA1 gene polymorphisms in chronic obstructive pulmonary disease. J Med Genet 41: e27, 2004.
16. Pauwels RA, Buist AS, Calverley PM, Jenkins CR and Hurd SS: GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163: 1256-1276, 2001.
17. Lohi J, Lehti K, Valtanen H, Parks WC and Keski-Oja J: Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene. Gene 242: 75-86, 2000.
18. Lewontin RC: On measures of gametic disequilibrium. Genetics 120: 849-852, 1988.
19. Shifman S, Bronstein M, Sternfeld M, et al: A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71: 1296-1302, 2002.
20. Leeman MF, Curran S and Murray GI: New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 201: 528-534, 2003.
21. Patel MI, Melrose J, Ghosh P and Appleberg M: Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg 24: 82-92, 1996. (Pubitemid 26271958)
22. Pap T, Shigeyama Y, Kuchen S, et al: Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum 43: 1226-1232, 2000.
23. Russell RE, Thorley A, Culpitt SV, et al: Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteinases. Am J Physiol Lung Cell Mol Physiol 283: L867-L873, 2002.
24. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M and Okada Y: Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272: 2446-2451, 1997.
25. Butler GS, Butler MJ, Atkinson SJ, et al: The TIMP2 membrane type 1 metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A: a kinetic study. J Biol Chem 273: 871-880, 1998.
26. Lander ES and Schork NJ: Genetic dissection of complex traits. Science 265: 2037-2048, 1994.
27. Van Laahoven CJ, Borstlap AC, van Berge Henegouwen DP, Palmen FM, Verpalen MC and Schoemaker MC: Chronic obstructive pulmonary disease and abdominal aortic aneurysms. Eur J Vasc Surg 7: 386-390, 1993.
28. Davis MJ: Aortic aneurysm formation: lessons from human studies and experimental models. Circulation 98: 193-195, 1999.
29. Nishimura K, Ikebuchi M, Kanaoka Y, et al: Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms. Int Angiol 22: 229-238, 2003. (Pubitemid 37483692)
30. Crowther M, Goodall S, Jones JL, Bell PR and Thompson MM: Localization of matrix metalloproteinase 2 within the aneurysm and normal aortic wall. Br J Surg 87: 1391-1400, 2000.
31. Hirano K, Sakamoto T, Uchida Y, et al: Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Eur Respir J 18: 748-752, 2001. (Pubitemid 33076914)
32. Hegab AE, Sakamoto T, Uchida Y, et al: Association analysis of tissue inhibitor of metalloproteinase2 gene polymorphisms with COPD in Egyptians. Respir Med 99: 107-110, 2005.
33. Wang X, Tromp G, Cole CW, et al: Analysis of coding sequences for tissue inhibitor of metalloproteinases 1 (TIMP1) and 2 (TIMP2) in patients with aneurysms. Matrix Biol 18: 121-124, 1999.